Search Results

You searched for : FDAapproval

	Oyster Point Pharma Announces FDA Approval of TYRVAYA (varenicline solution) Nasal spray for the treatment of the signs and symptoms of Dry Eye Disease... Oct 20
	U.S. FDA approves LIVMARLI (maralixibat) as the First and Only Approved Medication for the Treatment of Cholestatic Pruritus Indicated for patients with Alagille Syndrome one year of age and older... Oct 04
	ImmixBio announces FDA Orphan drug designation for IMX-110 for the treatment of Soft Tissue Sarcoma Latest pharma news update... Oct 04
	FDA approves Abbott's Amplatzer Talisman System for PFO Closure in people at risk of recurrent Stroke Latest Pharma News update... Oct 04
	Axsome Therapeutics announces FDA acceptance of New Drug Application for AXS-07 AXS-07 is indicated for the acute treatment of Migraine... Sep 16
	Versantis Receives U.S. FDA Orphan Drug Designation for VS-01 Latest pharma news updates... Sep 13
	Investigation finds nearly half of drugs granted FDA â€˜fast trackâ€™ approval lack proven clinical benefit Process plagued by missing efficacy data and questionable evidence with standards of evidence being too low ... Aug 02
	FDA Clearance of IND for FPI-1966, Radiopharmaceutical for Head and Neck and Bladder Cancers Expressing FGFR3 Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-1966 ... Jul 30
	FDA Clearance of IND for FPI-1966, Radiopharmaceutical for Head and Neck and Bladder Cancers Expressing FGFR3 Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-1966 ... Jul 30
	FDA Grants Alkeus Pharmaceuticals Breakthrough Therapy Designation for ALK-00 ; Stargardt Disease Latest FDA news update... Jul 16
	Sanofi extends collaboration with Genedata for Pharmaceutical Development & Manufacturing Science Latest FDA approvals update... Jul 16
	Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC Immutep was granted Fast Track designation for efti to treat 1st line HNSCC patients by the US FDA in early April 2021. ... Jul 12
	U.S. FDA approves finerenone for the treatment of patients with chronic kidney disease associated with type 2 diabetes Finerenone has also been submitted for marketing authorization in the European Union (EU) and in China... Jul 12
	FDA issues Actemra drug for COVID under Emergency Use Authorization (EUA) The drug, Actemra (tocilizumab) has shown efficacy in treating COVID patients with better results by reducing the death and mortality rate along with complications. FDA ... Jun 25
	Roche SARS-CoV-2 molecular test granted first FDA Emergency Use Authorization for PCR testing for Coronavirus Roche SARS-CoV-2 molecular test for PCR testing is effective for both symptomatic and asymptomatic Covid individuals ... Jun 22
	Bioheng Biotech received Orphan Drug Designation from the U.S. FDA for the treatment of T-ALL. New approval for treating leukomia... Jun 22
	Novartis receives FDA approval 177Lu-PSMA-617 for metastatic castration resistant prostate cancer FDA breakthrough therapy for Novartis metastatic prostate cancer drug ... Jun 21
	FDA grants accelerated approval for Alzheimerâ€™s Disease FDA shows hope to Alzheimerâ€™s Disease patients this year. The drug Aduhelm may provide a sigh of relief to the patients suffering from Alzheimerâ€™... Jun 09
	FDA authorizes monoclonal antibody therapy for emergency use in some patients 12 and older The authorization is specifically for those with mild-to-moderate Covid-19, who are at risk of getting much sicker... May 27
	FDA Approves GlaxoSmithKline's immunotherapy for Endometrial Cancer with specific biomarker GSK gets FDA nod for Jemperli indicated for endometrial cancer... Apr 26
	GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19 The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ... Mar 27
	GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19 The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ... Mar 27
	FDA approves new indication for drug to treat Neurogenic Detrusor Overactivity in pediatric Patients NDO is a dysfunction of the bladder that results from congenital conditions... Mar 26
	Precigen Receives FDA Orphan Drug Designation for PRGN-2012 Adenoverse The drug is used for immunotherapy in patients with Recurrent Respiratory Papillomatosis (RRP)... Mar 20
	BioXcel Therapeutics receives FDA Breakthrough Therapy Designation for BXCL501 for the acute treatment of Dementia Latest FDA approvals update... Mar 16
25 Matching result(s) found!

-Advertisements-

Trending Now
	Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
	MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
	World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
	Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
	Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
	University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
	Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
	Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
	UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
	SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
	Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
	The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
	The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
	KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
	Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
	CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
	World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
	From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
	Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
	CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025

Search Results

Oyster Point Pharma Announces FDA Approval of TYRVAYA (varenicline solution)

U.S. FDA approves LIVMARLI (maralixibat) as the First and Only Approved Medication for the Treatment of Cholestatic Pruritus

ImmixBio announces FDA Orphan drug designation for IMX-110 for the treatment of Soft Tissue Sarcoma

FDA approves Abbott's Amplatzer Talisman System for PFO Closure in people at risk of recurrent Stroke

Axsome Therapeutics announces FDA acceptance of New Drug Application for AXS-07

Versantis Receives U.S. FDA Orphan Drug Designation for VS-01

Investigation finds nearly half of drugs granted FDA â€˜fast trackâ€™ approval lack proven clinical benefit

FDA Clearance of IND for FPI-1966, Radiopharmaceutical for Head and Neck and Bladder Cancers Expressing FGFR3

FDA Clearance of IND for FPI-1966, Radiopharmaceutical for Head and Neck and Bladder Cancers Expressing FGFR3

FDA Grants Alkeus Pharmaceuticals Breakthrough Therapy Designation for ALK-00 ; Stargardt Disease

Sanofi extends collaboration with Genedata for Pharmaceutical Development & Manufacturing Science

Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC

U.S. FDA approves finerenone for the treatment of patients with chronic kidney disease associated with type 2 diabetes

FDA issues Actemra drug for COVID under Emergency Use Authorization (EUA)

Roche SARS-CoV-2 molecular test granted first FDA Emergency Use Authorization for PCR testing for Coronavirus

Bioheng Biotech received Orphan Drug Designation from the U.S. FDA for the treatment of T-ALL.

Novartis receives FDA approval 177Lu-PSMA-617 for metastatic castration resistant prostate cancer

FDA grants accelerated approval for Alzheimerâ€™s Disease

FDA authorizes monoclonal antibody therapy for emergency use in some patients 12 and older

FDA Approves GlaxoSmithKline's immunotherapy for Endometrial Cancer with specific biomarker

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

FDA approves new indication for drug to treat Neurogenic Detrusor Overactivity in pediatric Patients

Precigen Receives FDA Orphan Drug Designation for PRGN-2012 Adenoverse

BioXcel Therapeutics receives FDA Breakthrough Therapy Designation for BXCL501 for the acute treatment of Dementia

Trending Now